Clinical Trial Update: Faecal Microbiota Transplantation for Patients With Diabetes Mellitus Type 1 and Severe Gastrointestinal Neuropathy [NA]

View source ↗

Summary

A clinical trial evaluating faecal microbiota transplantation in patients with Type 1 diabetes mellitus and severe gastrointestinal neuropathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Neuropathy
• Type 1 Diabetes Mellitus

Drugs mentioned

• Faecal Microbiota Transplantation

Snippet

Sponsor: University of Aarhus | Conditions: Faecal Microbiota Transplantation (FMT), Diabetes Mellitus, Type 1 | NA | Status: COMPLETED